ABS-205

N/A

Report date: 2023/05/24 13:30:26
NME

Base Information

Drug NameABS-205
Drug Alias NameABS-200
ClassificationSmall molecules
Mechanisms of ActionNerve growth factor stimulants
TargetsNerve growth factor
Therapy Area/IndicationsSchizophreniaAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity College Dublin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSchizophreniaAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A